Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Short term Debt (2018 - 2025)

Neuronetics (STIM) has disclosed Short term Debt for 7 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt changed N/A to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a N/A change, with the full-year FY2024 number at $1.0 million, changed N/A from a year prior.
  • Short term Debt was $1.0 million for Q3 2025 at Neuronetics, roughly flat from $1.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $35.1 million in Q3 2021 to a low of $1.0 million in Q4 2024.
  • A 4-year average of $8.8 million and a median of $4.4 million in 2022 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: grew 1.63% in 2021, then plummeted 92.65% in 2025.
  • Neuronetics' Short term Debt stood at $35.1 million in 2021, then plummeted by 62.61% to $13.1 million in 2022, then tumbled by 92.38% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Short term Debt are $1.0 million (Q3 2025), $1.0 million (Q2 2025), and $1.0 million (Q1 2025).